Abstract
A population-based cohort was used to determine the incidence and risk factors associated with development of venous thromboembolism (VTE) among Californians diagnosed with acute leukemia between 1993 to 1999. Principal outcomes were deep vein thrombosis in both the lower and upper extremities, pulmonary embolism, and mortality. Among 5394 cases with acute myelogenous leukemia (AML), the 2-year cumulative incidence of VTE was 281 (5.2%). Sixty-four percent of the VTE events occurred within 3 months of AML diagnosis. In AML patients, female sex, older age, number of chronic comorbidities, and presence of a catheter were significant predictors of development of VTE within 1 year. A diagnosis of VTE was not associated with reduced survival in AML patients. Among 2482 cases with acute lymphoblastic leukemia (ALL), the 2-year incidence of VTE in ALL was 4.5%. Risk factors for VTE were presence of a central venous catheter, older age, and number of chronic comorbidities. In the patients with ALL, development of VTE was associated with a 40% increase in the risk of dying within 1 year. The incidence of VTE in acute leukemia is appreciable, and is comparable with the incidence in many solid tumors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3911-3917 |
| Number of pages | 7 |
| Journal | Blood |
| Volume | 113 |
| Issue number | 17 |
| DOIs | |
| State | Published - 2009 |
Fingerprint
ASJC Scopus subject areas
- Hematology
- Biochemistry
- Cell Biology
- Immunology
Cite this
Venous thromboembolism in patients with acute leukemia : Incidence, risk factors, and effect on survival. / Ku, Grace H.; White, Richard H; Chew, Helen K; Harvey, Danielle J; Zhou, Hong; Wun, Theodore.
In: Blood, Vol. 113, No. 17, 2009, p. 3911-3917.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Venous thromboembolism in patients with acute leukemia
T2 - Incidence, risk factors, and effect on survival
AU - Ku, Grace H.
AU - White, Richard H
AU - Chew, Helen K
AU - Harvey, Danielle J
AU - Zhou, Hong
AU - Wun, Theodore
PY - 2009
Y1 - 2009
N2 - A population-based cohort was used to determine the incidence and risk factors associated with development of venous thromboembolism (VTE) among Californians diagnosed with acute leukemia between 1993 to 1999. Principal outcomes were deep vein thrombosis in both the lower and upper extremities, pulmonary embolism, and mortality. Among 5394 cases with acute myelogenous leukemia (AML), the 2-year cumulative incidence of VTE was 281 (5.2%). Sixty-four percent of the VTE events occurred within 3 months of AML diagnosis. In AML patients, female sex, older age, number of chronic comorbidities, and presence of a catheter were significant predictors of development of VTE within 1 year. A diagnosis of VTE was not associated with reduced survival in AML patients. Among 2482 cases with acute lymphoblastic leukemia (ALL), the 2-year incidence of VTE in ALL was 4.5%. Risk factors for VTE were presence of a central venous catheter, older age, and number of chronic comorbidities. In the patients with ALL, development of VTE was associated with a 40% increase in the risk of dying within 1 year. The incidence of VTE in acute leukemia is appreciable, and is comparable with the incidence in many solid tumors.
AB - A population-based cohort was used to determine the incidence and risk factors associated with development of venous thromboembolism (VTE) among Californians diagnosed with acute leukemia between 1993 to 1999. Principal outcomes were deep vein thrombosis in both the lower and upper extremities, pulmonary embolism, and mortality. Among 5394 cases with acute myelogenous leukemia (AML), the 2-year cumulative incidence of VTE was 281 (5.2%). Sixty-four percent of the VTE events occurred within 3 months of AML diagnosis. In AML patients, female sex, older age, number of chronic comorbidities, and presence of a catheter were significant predictors of development of VTE within 1 year. A diagnosis of VTE was not associated with reduced survival in AML patients. Among 2482 cases with acute lymphoblastic leukemia (ALL), the 2-year incidence of VTE in ALL was 4.5%. Risk factors for VTE were presence of a central venous catheter, older age, and number of chronic comorbidities. In the patients with ALL, development of VTE was associated with a 40% increase in the risk of dying within 1 year. The incidence of VTE in acute leukemia is appreciable, and is comparable with the incidence in many solid tumors.
UR - http://www.scopus.com/inward/record.url?scp=65449163082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65449163082&partnerID=8YFLogxK
U2 - 10.1182/blood-2008-08-175745
DO - 10.1182/blood-2008-08-175745
M3 - Article
C2 - 19088376
AN - SCOPUS:65449163082
VL - 113
SP - 3911
EP - 3917
JO - Blood
JF - Blood
SN - 0006-4971
IS - 17
ER -